US PTO rejects several Plavix claims in "non-final" action
01 March 2010
Nancy Faigen
Please Login to read the full article.
01 March 2010
Nancy Faigen
The US Patent and Trademark Office issued a "non-final" office action rejecting several claims covering Sanofi-Aventis/ Bristol-Myers Squibb's Plavix (clopidogrel) in December, BMS has just revealed in an SEC regulatory filing.
The action occurred during the course of a re-examination...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for biopharma
- Supreme Court weighs patent validity standard of proof in Microsoft v. i4i
- US Capitol Capsule: Supreme Court to weigh generic drug liability, patent burden-of-proof standards
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
